Virginia Tech® home

Rare Disease as an Emerging and Distinct Field of Medicine

Insert your title here

Marshall Summar, M.D.

Chief, Division of Genetics and Metabolism
Director, Rare Disease Institute
Magaret O'Malley Chair, Genetic Medicine
Children's National Hospital

Rare Disease as an Emerging and Distinct Field of Medicine

Date: Aug. 30, 2022

Time:  1 - 2 p.m.

About this Seminar

With the completion of the human genome sequence and the advent of affordable molecular sequencing, the field of genetic rare diseases has exploded. With over 8000 conditions described (and counting), the classic expectation of a physicians encyclopedic knowledge of their field is unrealistic. The pace of therapeutic development for rare disease is also explosive with 52% of new drugs approved by the FDA for rare diseases. This lecture will describe this oncoming wave and discuss new models that can be used to care for patients.

You May Also Be Interested In...

  • Home Item
    The Role of Exercise in Memory Function
    The Role of Exercise in Memory Function , home

    May 23, 2025, 11:00 a.m. | Henriette van Praag, Ph.D., Associate Professor, Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute

  • Home Item
    Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes
    Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes , home

    May 30, 2025, 11:00 a.m. | Gea-Ny Tseng, Ph.D., Professor, Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research

  • Home Item
    Targeting Acquired Dependencies During Tumor Evolution
    Targeting Acquired Dependencies During Tumor Evolution , home

    June 6, 2025, 11:00 a.m. | Kris Wood, Ph.D., Associate Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.